Response Genetics agrees to testing deal with MultiPlan

|About: Response Genetics, Inc. (RGDX)|By:, SA News Editor

Response Genetics (RGDX) forges an agreement to provide its testing products to MultiPlan, a provider of healthcare cost-management products.

Response Genetics' tests help predict patients' response to cancer therapy and thereby place them on the most effective drug regimen.

Response Genetics' shares +11.7%. (PR)